SEC Form 4 · accession 0001628280-26-045374
BECTON DICKINSON & CO · BDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Garrison
Officer — EVP & Pres Med.Essntl&BioPharm
Period of report
Jun 24, 2026
Accepted (ET)
Jun 25, 2026 · 10:16 am EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000010795
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 24, 2026 | S | 1,100 | $145.66 | D | 13,172 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The reported transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 18, 2026.